CTDSP2 and neoplasm: Next, genes with a significantly higher level in these malignant iCCA patients and iCCA cells were explored via comparing tumor transcriptomic profiles of MShigh patients vs. MSlow patients in three iCCA cohorts and proteomic profiles of OS4-GFP+ vs. OS4-GFP− RBE cells.